Literature DB >> 15656926

Pathogenesis of reflux esophagitis and Barrett's esophagus.

Roy C Orlando1.   

Abstract

An understanding of the pathogenesis of reflux esophagitis and Barrett's esophagus requires knowledge of the noxious elements in gastric juice and the three major esophageal defenses designed to protect against them. When the esophageal epithelium cannot prevent gastric acid from acidifying the intercellular spaces, the foundation is set for the development of the major symptoms, signs, and complications of reflux esophagitis. Inadequate defense by the epithelium can occur by exposure to the acidic refluxate for a prolonged period of time, because of defects in the antireflux or luminal clearance mechanisms, or by exposure to ingested products that directly impair the epithelium's intrinsic defenses, rendering it vulnerable to injury from even physiologic levels of acid reflux.

Entities:  

Mesh:

Year:  2005        PMID: 15656926     DOI: 10.1016/j.mcna.2004.08.006

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  9 in total

1.  Exposure to both radiation and chemotherapy increases the risk of Barrett's and multilayered epithelium.

Authors:  Helen M Shields; Abram Recht; Helen H Wang
Journal:  Dig Dis Sci       Date:  2008-12-18       Impact factor: 3.199

Review 2.  The integrity of the esophageal mucosa. Balance between offensive and defensive mechanisms.

Authors:  Roy C Orlando
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-12       Impact factor: 3.043

3.  The impact of reflux composition on mucosal injury and esophageal function.

Authors:  Daniel S Oh; Jeffrey A Hagen; Martin Fein; Cedric G Bremner; Christy M Dunst; Steven R Demeester; John Lipham; Tom R Demeester
Journal:  J Gastrointest Surg       Date:  2006-06       Impact factor: 3.452

Review 4.  Pathophysiology and treatment of Barrett's esophagus.

Authors:  Daniel S Oh; Steven R Demeester
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

5.  Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes.

Authors:  Kerry B Dunbar; Agoston T Agoston; Robert D Odze; Xiaofang Huo; Thai H Pham; Daisha J Cipher; Donald O Castell; Robert M Genta; Rhonda F Souza; Stuart J Spechler
Journal:  JAMA       Date:  2016-05-17       Impact factor: 56.272

6.  Orally administered L-arginine and glycine are highly effective against acid reflux esophagitis in rats.

Authors:  Kenji Nagahama; Hikaru Nishio; Masanori Yamato; Koji Takeuchi
Journal:  Med Sci Monit       Date:  2012-01

7.  The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus.

Authors:  Sheetal Hardikar; Lynn Onstad; Patricia L Blount; Robert D Odze; Brian J Reid; Thomas L Vaughan
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

8.  Multilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers.

Authors:  Xiaoxin Chen; Rong Qin; Ba Liu; Yan Ma; Yinghao Su; Chung S Yang; Jonathan N Glickman; Robert D Odze; Nicholas J Shaheen
Journal:  BMC Gastroenterol       Date:  2008-01-11       Impact factor: 3.067

9.  Upper gastrointestinal cancer and reflux disease.

Authors:  Jin-Jo Kim
Journal:  J Gastric Cancer       Date:  2013-06-25       Impact factor: 3.720

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.